Fingerprint
Dive into the research topics of 'Sarpogrelate, a 5-HT2A receptor antagonist in intermittent claudication. A Phase II European study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Sarpogrelate, a 5-HT2A receptor antagonist in intermittent claudication. A Phase II European study
L. Norgren, A. Jawien, L. Matyas, H. Rieger, K. Arita, J. J. F. Belch, European MCI-9042 Study Group
Research output: Contribution to journal › Article › peer-review
29
Citations
(Scopus)